Dr. Haase is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
3601 The Vanderbilt Clinic
Nashville, TN 37232Phone+1 615-322-3000
Education & Training
Beth Israel Deaconess Medical CenterFellowship, Nephrology, 1999
Goethe University Frankfurt Medical FacultyClass of 1987, Dr. med., magna cum laude
Emory University School of MedicineResidency, Internal Medicine
Massachusetts General HospitalGenetics
Whitehead Institute for Biomedical ResearchPost-Doctoral Fellowship, Molecular Biology/Genetics
Publications & Presentations
PubMed
- Hypoxia-inducible factor activators: a novel class of oral drugs for the treatment of anemia of chronic kidney disease.Volker H Haase, Tetsuhiro Tanaka, Mark J Koury
Hematology. American Society of Hematology. Education Program. 2024-12-06 - Disruption of mitochondrial electron transport impairs urinary concentration via AMPK-dependent suppression of aquaporin 2.Joshua S Carty, Ryoichi Bessho, Yvonne Zuchowski, Jonathan B Trapani, Olena Davidoff
JCI Insight. 2024-11-22 - 1 citationsDisruption of nucleotide biosynthesis reprograms mitochondrial metabolism to inhibit adipogenesis.Julia A Pinette, Jacob W Myers, Woo Yong Park, Heather G Bryant, Alex M Eddie
Journal of Lipid Research. 2024-10-01
Press Mentions
- #NephMadness 2021: HIF-PHIs – the New Kids on the Block in Anemia Therapy and Much MoreMarch 4th, 2021
p53/microRNA-214/ULK1 Axis Impairs Renal Tubular Autophagy in Diabetic Kidney DiseaseAugust 17th, 2020
Medical Societies Honor Four VUMC PhysiciansMay 12th, 2016
External Links
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
